X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55) 55
index medicus (41) 41
male (25) 25
female (24) 24
cell line, tumor (22) 22
aged (19) 19
middle aged (19) 19
oncology (16) 16
lung neoplasms - drug therapy (15) 15
pharmacology & pharmacy (15) 15
adult (14) 14
carcinoma, non-small-cell lung - drug therapy (14) 14
lung cancer, non-small cell (14) 14
non-small cell lung cancer (14) 14
lung neoplasms - pathology (13) 13
chemotherapy (12) 12
lung cancer (12) 12
cell survival - drug effects (11) 11
drug synergism (11) 11
erk1/2 (11) 11
taiwan (11) 11
taiwan - epidemiology (11) 11
homologous recombination (10) 10
in-vitro (10) 10
respiratory system (10) 10
risk factors (10) 10
activation (9) 9
cancer (9) 9
cytotoxicity (9) 9
prevalence (9) 9
rad51 (9) 9
rad51 recombinase - genetics (9) 9
aged, 80 and over (8) 8
carcinoma, non-small-cell lung - pathology (8) 8
cisplatin (8) 8
dose-response relationship, drug (8) 8
electricity (8) 8
gefitinib (8) 8
lung neoplasms - enzymology (8) 8
lung neoplasms - genetics (8) 8
rheumatology (8) 8
tyrosine (8) 8
antineoplastic agents - pharmacology (7) 7
carcinoma, non-small-cell lung - enzymology (7) 7
dna-damage (7) 7
epidermal growth factor (7) 7
epidermal-growth-factor (7) 7
lung neoplasms - metabolism (7) 7
map kinase kinase 1 - metabolism (7) 7
mitogen-activated protein kinase 1 - metabolism (7) 7
mitogen-activated protein kinase 3 - metabolism (7) 7
research (7) 7
time factors (7) 7
transfection (7) 7
akt (6) 6
carcinoma, non-small-cell lung - metabolism (6) 6
cell proliferation - drug effects (6) 6
down-regulation (6) 6
erlotinib (6) 6
gout (6) 6
induced apoptosis (6) 6
proteasome endopeptidase complex - metabolism (6) 6
protein (6) 6
quinazolines - pharmacology (6) 6
rad51 recombinase - biosynthesis (6) 6
resistance (6) 6
toxicology (6) 6
tuberculosis (6) 6
adolescent (5) 5
basic electric elements (5) 5
blasting (5) 5
breast-cancer (5) 5
carcinoma, non-small-cell lung - genetics (5) 5
care and treatment (5) 5
cell biology (5) 5
details of heat-exchange and heat-transfer apparatus, ofgeneral application (5) 5
electric solid state devices not otherwise provided for (5) 5
expression (5) 5
gene expression regulation, neoplastic - drug effects (5) 5
gene-expression (5) 5
growth-factor receptor (5) 5
health aspects (5) 5
heat exchange in general (5) 5
heating (5) 5
lighting (5) 5
mechanical engineering (5) 5
nucleotide excision-repair (5) 5
proto-oncogene proteins c-akt - metabolism (5) 5
semiconductor devices (5) 5
tumor-cells (5) 5
tyrosine kinase inhibitor (5) 5
weapons (5) 5
women (5) 5
adenocarcinoma (4) 4
analysis (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cardiovascular-disease (4) 4
casings or constructional details of electric apparatus (4) 4
cisplatin - pharmacology (4) 4
cohort studies (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, ISSN 1058-4838, 03/2017, Volume 64, Issue 6, pp. 719 - 727
Background. Despite the well-documented association between diabetes and active tuberculosis, evidence of the association between diabetes and latent... 
latent tuberculosis infection | metaanalysis | diabetes mellitus | systemic review | CONTACTS | INFECTIOUS DISEASES | ASSAY | INTERFERON-GAMMA RELEASE | BIAS | RISK | MICROBIOLOGY | PREVALENCE | IMMUNOLOGY | HIV | BURDEN | Complications and side effects | Diabetics | Tuberculosis | Medical examination | Diabetes | Health aspects | Risk factors | Major
Journal Article
Scientific reports, ISSN 2045-2322, 2019, Volume 9, Issue 1, pp. 9478 - 9
... in-hospital cardiopulmonary resuscitation: a population-based cohort study Meng-Rui Lee 1,2,5, Kai-Lun Yu 1,2, Hung-Yang Kuo 1,3, Tsung-Hao Liu1,3, Jen-Chung Ko1,2, Jaw... 
OF-LIFE CARE | SURVIVAL | CARDIAC-ARREST | QUALITY | TAIWAN | PREFERENCES | MULTIDISCIPLINARY SCIENCES | ORDERS | Population studies | Cardiopulmonary resuscitation--CPR | Survival | Mortality | Cancer
Journal Article
The European respiratory journal, ISSN 0903-1936, 08/2017, Volume 50, Issue 2, pp. 1700851 - 1700851
There are still several unanswered research questions regarding tuberculosis (TB) contact investigations [1–4]. For example, up-to-date epidemiological studies... 
RESPIRATORY SYSTEM | INFECTION | Tuberculosis - epidemiology | Humans | Middle Aged | Proportional Hazards Models | Child, Preschool | Cost of Illness | Infant | Male | Contact Tracing - statistics & numerical data | Young Adult | Taiwan - epidemiology | Adolescent | Aged, 80 and over | Adult | Female | Aged | Child | Infant, Newborn | Cohort Studies | Epidemiology | Risk factors | Tuberculosis
Journal Article
Journal of the Formosan Medical Association, ISSN 0929-6646, 01/2020, Volume 119, Issue 1, pp. 367 - 376
Little remains known regarding whether newer FQ with less anti-mycobacterial activity (gemifloxacin) would reduce treatment delay. We identified one... 
Gemifloxacin | Beta-lactam | Treatment delay | Fluoroquinolone | Tuberculosis | MYCOBACTERIUM-TUBERCULOSIS | DIAGNOSIS | COMMUNITY-ACQUIRED PNEUMONIA | RESISTANT | MEDICINE, GENERAL & INTERNAL | NEMONOXACIN | IN-VITRO ACTIVITIES | PULMONARY TUBERCULOSIS | OUTCOMES | EXPOSURE | Drug therapy
Journal Article
Oncotarget, ISSN 1949-2553, 2017, Volume 8, Issue 52, pp. 90430 - 90443
Journal Article
Oncotarget, ISSN 1949-2553, 05/2018, Volume 9, Issue 34, pp. 23749 - 23760
Lung cancer remains the primary cause of cancer-related mortality worldwide. Several treatment modalities are available for lung cancer, including surgery,... 
Prognostic factor | Afatinib | Real-world study | First-line therapy | EGFR mutation-positive lung adenocarcinoma
Journal Article
Cancer medicine (Malden, MA), ISSN 2045-7634, 2017, Volume 6, Issue 7, pp. 1563 - 1572
Among treatment modalities for lung cancer, the most promising therapy is the use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs).... 
overall survival | epidermal growth factor receptor‐tyrosine kinase inhibitor | chemotherapy | non–small‐cell lung cancer | progression‐free survival | epidermal growth factor receptor-tyrosine kinase inhibitor | non–small-cell lung cancer | progression-free survival | SOLID TUMORS | ADENOCARCINOMA | EGFR MUTATIONS | OPEN-LABEL | TRIAL | PROGNOSTIC-FACTOR | ONCOLOGY | RANDOMIZED PHASE-III | 2ND-LINE TREATMENT | TYROSINE KINASE INHIBITOR | non-small-cell lung cancer | Lung Neoplasms - drug therapy | Prognosis | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Non-Small-Cell Lung - diagnosis | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Antineoplastic Agents - adverse effects | Aged, 80 and over | Female | Quinazolines - administration & dosage | Registries | Gefitinib | Severity of Illness Index | Erlotinib Hydrochloride - adverse effects | Comorbidity | Erlotinib Hydrochloride - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Non-Small-Cell Lung - epidemiology | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Propensity Score | Protein Kinase Inhibitors - administration & dosage | Retreatment | Lung Neoplasms - epidemiology | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Taiwan - epidemiology | Quinazolines - adverse effects | Aged | Erlotinib Hydrochloride - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Lung Neoplasms - diagnosis | Cohort Studies | Care and treatment | Chemotherapy | Epidermal growth factor | Erlotinib | Analysis | Oncology, Experimental | Development and progression | Research | Lung cancer, Non-small cell | Cancer | Tyrosine | Adenocarcinoma | Sensitivity analysis | Epidermal growth factor receptors | Lung cancer | Clinical trials | Non-small cell lung carcinoma | Patients | Survival analysis | Protein-tyrosine kinase receptors | Health risk assessment | Protein-tyrosine kinase
Journal Article
Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, 12/2015, Volume 117, Issue 6, pp. 383 - 391
Etoposide (VP‐16), a topoisomerase II inhibitor, is an effective anti‐cancer drug used for the treatment of non‐small‐cell lung cancer (NSCLC). Resveratrol is... 
IN-VITRO | PROSTATE CARCINOMA | CISPLATIN | INDUCED APOPTOSIS | GASTRIC-CANCER | DNA | EPIDERMAL-GROWTH-FACTOR | GENES XRCC1 | MOUSE | PHARMACOLOGY & PHARMACY | TOXICOLOGY | IONIZING-RADIATION | Lung Neoplasms - drug therapy | Phosphorylation | Humans | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Stilbenes - pharmacology | Proto-Oncogene Proteins c-akt - genetics | Antineoplastic Combined Chemotherapy Protocols - pharmacology | DNA-Binding Proteins - metabolism | Dose-Response Relationship, Drug | MAP Kinase Kinase 1 - genetics | Transfection | RNA Interference | Time Factors | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Cell Survival - drug effects | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Down-Regulation | Etoposide - pharmacology | MAP Kinase Kinase 1 - metabolism | DNA-Binding Proteins - genetics | Gene Expression Regulation, Enzymologic | Mitogen-Activated Protein Kinase 3 - metabolism | Signal Transduction - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | X-ray Repair Cross Complementing Protein 1 | Drug Resistance, Neoplasm - drug effects | Mitogen-Activated Protein Kinase 1 - metabolism | Etoposide | Development and progression | Lung cancer, Non-small cell | Resveratrol
Journal Article
Journal of the Formosan Medical Association, ISSN 0929-6646, 01/2020, Volume 119, Issue 1, pp. 538 - 543
This study analyzed the effects of the General Medicine Faculty Training Program (GMFTP), which was implemented in 2009. The training program includes a 7-hour... 
Core competencies | General medicine faculty training program | Teaching confidence | Knowledge improvement | MEDICINE, GENERAL & INTERNAL | COMPETENCES | EDUCATION
Journal Article
Carcinogenesis, ISSN 0143-3334, 7/2008, Volume 29, Issue 7, pp. 1448 - 1458
Journal Article
Journal Article